Add to ORKGthe incidence of peptic ulcer decreased since the introduction od proton pump inhibitors as the consequence of prevention of NSAI correlated peptic ulcer
The association between NSAIDs and the presence of upper gastrointestinal (GI) complications is well...
The discovery of Helicobacter pylori has greatly changed our approach to peptic ulcer disease. Bacte...
Currently, proton pump inhibitors are used in a wide range of patients with gastroesophageal reflux ...
Abstract Background Despite a decreasing incidence of peptic ulcer disease, most previous studies re...
BACKGROUND: Despite a decreasing incidence of peptic ulcer disease, most previous studies report a s...
Treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by gastrointestinal ulcer ...
Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used ...
Purpose: To determine which patients are especially at risk for serious NSAID attributable gastroduo...
Few epidemiologic studies have investigated predictors of uncomplicated peptic ulcer disease (PUD) s...
Peptic ulcer disease (PUD) is predicted to affect between 0.1 and 0.3 percent of the population each...
Few epidemiologic studies have investigated predictors of uncomplicated peptic ulcer disease (PUD) s...
Non-steroidal anti-inflammatory drugs (NSAIDs) and proton pump inhibitors (PPIs) are regarded as two...
Purpose:\ud To determine which patients are especially at risk for serious NSAID attributable gastro...
Today, the lifetime prevalence of peptic ulcer disease is in industrialized countries approximately ...
Objective: Proton pump inhibitors (PPIs) are recommended for preventing gastrointestinal lesions ind...
The association between NSAIDs and the presence of upper gastrointestinal (GI) complications is well...
The discovery of Helicobacter pylori has greatly changed our approach to peptic ulcer disease. Bacte...
Currently, proton pump inhibitors are used in a wide range of patients with gastroesophageal reflux ...
Abstract Background Despite a decreasing incidence of peptic ulcer disease, most previous studies re...
BACKGROUND: Despite a decreasing incidence of peptic ulcer disease, most previous studies report a s...
Treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by gastrointestinal ulcer ...
Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used ...
Purpose: To determine which patients are especially at risk for serious NSAID attributable gastroduo...
Few epidemiologic studies have investigated predictors of uncomplicated peptic ulcer disease (PUD) s...
Peptic ulcer disease (PUD) is predicted to affect between 0.1 and 0.3 percent of the population each...
Few epidemiologic studies have investigated predictors of uncomplicated peptic ulcer disease (PUD) s...
Non-steroidal anti-inflammatory drugs (NSAIDs) and proton pump inhibitors (PPIs) are regarded as two...
Purpose:\ud To determine which patients are especially at risk for serious NSAID attributable gastro...
Today, the lifetime prevalence of peptic ulcer disease is in industrialized countries approximately ...
Objective: Proton pump inhibitors (PPIs) are recommended for preventing gastrointestinal lesions ind...
The association between NSAIDs and the presence of upper gastrointestinal (GI) complications is well...
The discovery of Helicobacter pylori has greatly changed our approach to peptic ulcer disease. Bacte...
Currently, proton pump inhibitors are used in a wide range of patients with gastroesophageal reflux ...